Virotherapy of digestive tumors with rodentparvovirus: overview and perspectives

Pancreatic adenocarcinoma upregulated factor (PAUF) confers resistance to pancreatic cancer cells against oncolytic parvovirus H-1 infection through IFNA receptor-mediated signaling

(2015) Sirichat Kaowinn et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

(2015) Robert H.I. Andtbacka et al.   JOURNAL OF CLINICAL ONCOLOGY

Oncolytic parvoviruses: from basic virology to clinical applications

(2015) Antonio Marchini et al.   Virology Journal

Complementary Induction of Immunogenic Cell Death by Oncolytic Parvovirus H-1PV and Gemcitabine in Pancreatic Cancer

(2014) A. L. Angelova et al.   JOURNAL OF VIROLOGY

Consensus guidelines for the detection of immunogenic cell death

(2014) Oliver Kepp et al.   OncoImmunology

NK-cell-dependent killing of colon carcinoma cells is mediated by natural cytotoxicity receptors (NCRs) and stimulated by parvovirus infection of target cells

(2013) Rauf Bhat et al.   BMC CANCER

Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas

(2013) Junwei Li et al.   EMBO Molecular Medicine

Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer

(2013) Jeong Heo et al.   NATURE MEDICINE

TLR-9 Contributes to the Antiviral Innate Immune Sensing of Rodent Parvoviruses MVMp and H-1PV by Normal Human Immune Cells

(2013) Zahari Raykov et al.   PLoS One

Oncosuppressive Suicide Gene Virotherapy “PVH1-yCD/5-FC” for Pancreatic Peritoneal Carcinomatosis Treatment: NFκB and Akt/PI3K Involvement

(2013) Soukaina Réjiba et al.   PLoS One

Capacity of wild-type and chemokine-armed parvovirus H-1PV for inhibiting neo-angiogenesis

(2013) Muriel Lavie et al.   VIROLOGY

Influence of the oncolytic parvovirus H-1, CTLA-4 antibody tremelimumab and cytostatic drugs on the human immune system in a human in vitro model of colorectal cancer cells

(2013) Bernd Heinrich et al.   OncoTargets and Therapy

Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol

(2012) Karsten Geletneky et al.   BMC CANCER

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Antitumoral activity of parvovirus-mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer: implication of leucocyte recruitment

(2012) Sebastian Dempe et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Oncolytic Virus Therapy for Glioblastoma Multiforme

(2012) Guido Wollmann et al.   CANCER JOURNAL

Molecular Pathways: Rodent Parvoviruses--Mechanisms of Oncolysis and Prospects for Clinical Cancer Treatment

(2012) J. P. F. Nuesch et al.   CLINICAL CANCER RESEARCH

Oncolytic reovirus type 3 (Dearing) as a novel therapy in head and neck cancer

(2012) Joan N Kyula et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Effect of the parvovirus H-1 non-structural protein NS1 on the tumorigenicity of human gastric cancer cells

(2012) Yuan Yuan WANG et al.   Journal of Digestive Diseases

Immune cells participate in the oncosuppressive activity of parvovirus H-1PV and are activated as a result of their abortive infection with this agent

(2011) Svitlana P. Grekova et al.   CANCER BIOLOGY & THERAPY

Interferon γ improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer

(2011) Svitlana P. Grekova et al.   CANCER BIOLOGY & THERAPY

Enhancement of NK cell antitumor responses using an oncolytic parvovirus

(2010) Rauf Bhat et al.   INTERNATIONAL JOURNAL OF CANCER

Improved Killing of Human High-Grade Glioma Cells by Combining Ionizing Radiation with Oncolytic Parvovirus H-1 Infection

(2010) Karsten Geletneky et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV

(2009) A. L. Angelova et al.   CLINICAL CANCER RESEARCH

Oncolytic Rat Parvovirus H-1PV, a Candidate for the Treatment of Human Lymphoma: In Vitro and In Vivo Studies

(2009) Assia L Angelova et al.   MOLECULAR THERAPY

TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma

(2008) M Enderlin et al.   CANCER GENE THERAPY

Oncolytic viruses: a novel form of immunotherapy

(2008) Robin J Prestwich et al.   Expert Review of Anticancer Therapy

Arming parvoviruses with CpG motifs to improve their oncosuppressive capacity

(2008) Zahari Raykov et al.   INTERNATIONAL JOURNAL OF CANCER